Update shared on 12 Dec 2025
Fair value Increased 18%Analysts have raised their price target on Redox from 2.68 dollars to 3.16 dollars, citing a higher expected future price-to-earnings multiple, despite moderating assumptions for revenue growth and profit margins and a slightly higher discount rate.
Valuation Changes
- Fair Value: Increased from A$2.68 to A$3.16, representing a moderate upward revision to the target valuation.
- Discount Rate: Risen slightly from 7.55 percent to 7.57 percent, reflecting a marginally higher perceived risk or required return.
- Revenue Growth: Reduced meaningfully from 13.98 percent to 10.55 percent, indicating more conservative expectations for top line expansion.
- Net Profit Margin: Fallen slightly from 7.08 percent to 6.61 percent, pointing to modestly lower anticipated profitability.
- Future P/E: Increased significantly from 14.1x to 18.6x, implying a higher valuation multiple applied to expected earnings.
Have other thoughts on Redox?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.